Why the study?
Does serum cystatin C concentration correlate with the severity of coronary artery disease in patients without chronic kidney disease?
Does serum cystatin C concentration correlate with the severity of coronary artery disease in patients without chronic kidney disease?
Elevated serum cystatin C is associated with more severe coronary artery disease even in patients with normal estimated glomerular filtration rate, suggesting its utility as a marker of CAD severity independent of CKD.
Elevated cystatin C was associated with more severe CAD in non-CKD patients; leaves open incremental prognostic value beyond eGFR.
No takes yet. Share an insight, caveat, or question.
Kiyosue et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: